CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.02
0.97%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.08
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.03
Open* 0.99
1-Year Change* -67.43%
Day's Range* 0.99 - 1.05
52 wk Range 0.09-1.89
Average Volume (10 days) 1.90M
Average Volume (3 months) 30.52M
Market Cap 5.15M
P/E Ratio -100.00K
Shares Outstanding 46.00M
Revenue 10.23M
EPS -0.68
Dividend (Yield %) N/A
Beta 2.28
Next Earnings Date Mar 27, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 23, 2024 1.02 0.03 3.03% 0.99 1.06 0.99
Feb 22, 2024 1.03 0.00 0.00% 1.03 1.07 1.02
Feb 21, 2024 1.04 -0.02 -1.89% 1.06 1.06 1.01
Feb 20, 2024 1.05 -0.14 -11.76% 1.19 1.19 1.00
Feb 16, 2024 1.05 0.10 10.53% 0.95 1.06 0.95
Feb 15, 2024 0.85 0.01 1.19% 0.84 0.92 0.80
Feb 14, 2024 0.84 0.00 0.00% 0.84 0.86 0.82
Feb 13, 2024 0.84 0.03 3.70% 0.81 0.86 0.79
Feb 12, 2024 0.81 -0.02 -2.41% 0.83 0.86 0.79
Feb 9, 2024 0.78 0.01 1.30% 0.77 0.85 0.73
Feb 8, 2024 0.75 -0.07 -8.54% 0.82 0.82 0.74
Feb 7, 2024 0.79 0.23 41.07% 0.56 0.98 0.53
Feb 6, 2024 0.59 -0.07 -10.61% 0.66 0.66 0.54
Feb 5, 2024 0.64 0.11 20.75% 0.53 0.67 0.51
Feb 2, 2024 0.51 0.00 0.00% 0.51 0.52 0.49
Feb 1, 2024 0.51 0.06 13.33% 0.45 0.51 0.45
Jan 31, 2024 0.46 -0.01 -2.13% 0.47 0.48 0.46
Jan 30, 2024 0.46 0.07 17.95% 0.39 0.46 0.39
Jan 24, 2024 0.38 -0.01 -2.56% 0.39 0.39 0.38
Jan 23, 2024 0.38 -0.01 -2.56% 0.39 0.39 0.38

Cesca Therapeutics Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 9.294 9.744 13.047 9.672 6.013
Revenue 9.294 9.744 13.047 9.672 6.013
Cost of Revenue, Total 5.801 8.485 7.351 7.479 3.858
Gross Profit 3.493 1.259 5.696 2.193 2.155
Total Operating Expense 15.873 18.639 18.62 53.217 10.611
Selling/General/Admin. Expenses, Total 8.515 7.677 8.033 9.645 4.507
Research & Development 2.209 2.477 2.396 3.012 2.246
Unusual Expense (Income) -0.652 0 0.84 33.081 0
Operating Income -6.579 -8.895 -5.573 -43.545 -4.598
Interest Income (Expense), Net Non-Operating -6.103 -7.921 -4.493 -2.101 -0.408
Other, Net 0.802 0.005 -0.033 -0.024 -0.002
Net Income Before Taxes -11.88 -16.811 -10.099 -45.67 -5.008
Net Income After Taxes -11.88 -16.811 -10.099 -40.94 10.888
Net Income Before Extra. Items -11.379 -16.351 -9.497 -39.716 11.375
Net Income -11.379 -16.351 -9.497 -39.716 -2.283
Income Available to Common Excl. Extra. Items -11.379 -16.351 -9.497 -39.716 11.375
Income Available to Common Incl. Extra. Items -11.379 -16.351 -9.497 -39.716 -2.283
Diluted Net Income -11.379 -16.351 -9.497 -39.716 -2.283
Diluted Weighted Average Shares 11.7961 6.27799 2.82861 1.84128 1.01083
Diluted EPS Excluding Extraordinary Items -0.96464 -2.6045 -3.35748 -21.5698 11.2531
Diluted Normalized EPS -1.01992 -2.6045 -3.06052 -9.89167 11.4524
Minority Interest 0.501 0.46 0.602 1.224 0.487
Total Extraordinary Items 0 -13.658
Dividends per Share - Common Stock Primary Issue 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 2.663 2.418 3.158 2.201 1.517
Revenue 2.663 2.418 3.158 2.201 1.517
Cost of Revenue, Total 1.723 1.734 2.043 1.215 0.809
Gross Profit 0.94 0.684 1.115 0.986 0.708
Total Operating Expense 3.872 3.743 4.263 5.339 2.528
Selling/General/Admin. Expenses, Total 1.693 1.344 1.677 3.502 1.992
Research & Development 0.456 0.665 0.543 0.622 0.379
Unusual Expense (Income) 0 0 0 0 -0.652
Operating Income -1.209 -1.325 -1.105 -3.138 -1.011
Interest Income (Expense), Net Non-Operating -0.823 -1.53 -1.53 -1.524 -1.519
Other, Net -0.004 -0.031 0.843 -0.01 -0.001
Net Income Before Taxes -2.036 -2.886 -1.792 -4.672 -2.531
Net Income After Taxes -2.036 -2.886 -1.792 -4.672 -2.531
Minority Interest 0.126 0.232 0.018 0.133 0.118
Net Income Before Extra. Items -1.91 -2.654 -1.774 -4.539 -2.413
Net Income -1.91 -2.654 -1.774 -4.539 -2.413
Income Available to Common Excl. Extra. Items -1.91 -2.654 -1.774 -4.539 -2.413
Income Available to Common Incl. Extra. Items -1.91 -2.654 -1.774 -4.539 -2.413
Diluted Net Income -1.91 -2.654 -1.774 -4.539 -2.413
Diluted Weighted Average Shares 12.2885 11.9126 11.9118 11.9118 11.4464
Diluted EPS Excluding Extraordinary Items -0.15543 -0.22279 -0.14893 -0.38105 -0.21081
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.15543 -0.22279 -0.14893 -0.38105 -0.26777
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 14.964 15.298 9.861 8.626 11.454
Cash and Short Term Investments 7.28 7.161 3.157 2.4 3.513
Cash & Equivalents 7.28 7.161 3.157 2.4 3.513
Total Receivables, Net 0.733 1.382 1.278 1.509 2.549
Accounts Receivable - Trade, Net 0.733 1.382 1.278 1.509 2.549
Total Inventory 5.373 5.877 3.824 4.493 4.798
Prepaid Expenses 1.578 0.878 0.602 0.224 0.594
Total Assets 20.652 20.86 15.214 14.611 51.111
Property/Plant/Equipment, Total - Net 1.832 2.154 2.887 2.562 2.996
Goodwill, Net 0.781 0.781 0.781 0.781 13.976
Intangibles, Net 1.318 1.358 1.467 1.591 21.629
Other Long Term Assets, Total 1.757 1.256 0.21 1.051 1.056
Total Current Liabilities 6.348 6.143 6.685 6.365 5.464
Accounts Payable 1.28 1.366 1.447 2.423 2.079
Accrued Expenses 2.785 2.431 2.157 2.216 0.532
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 1.47 1.899 3.081 1.726 2.853
Total Liabilities 16.824 15.06 14.828 6.169 17.412
Total Long Term Debt 9.245 6.627 4.931 1.174 6.7
Long Term Debt 9.245 6.627 4.931 1.174 6.7
Deferred Income Tax 0 4.73
Other Liabilities, Total 1.662 2.22 2.682 0.341 1.005
Total Equity 3.828 5.8 0.386 8.442 33.699
Preferred Stock - Non Redeemable, Net 0 0
Common Stock 0.012 0.009 0.003 0.022 0.011
Additional Paid-In Capital 268.447 259.058 237.313 235.868 221.371
Retained Earnings (Accumulated Deficit) -264.662 -253.283 -236.932 -227.435 -187.64
Other Equity, Total 0.031 0.016 0.002 -0.013 -0.043
Total Liabilities & Shareholders’ Equity 20.652 20.86 15.214 14.611 51.111
Total Common Shares Outstanding 11.9118 8.93495 2.8436 2.16491 1.08724
Minority Interest -0.431 0.07 0.53 -1.711 -0.487
Other Current Assets, Total 0 1
Property/Plant/Equipment, Total - Gross 8.66 8.553 8.785
Accumulated Depreciation, Total -6.828 -6.399 -5.898
Long Term Investments 0.013 0.008
Current Port. of LT Debt/Capital Leases 0.813 0.447
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 13.194 14.964 16.881 16.077 16.904
Cash and Short Term Investments 3.652 7.28 7.634 8.668 10.014
Cash & Equivalents 3.652 7.28 7.634 8.668 10.014
Total Receivables, Net 2.175 0.733 2.571 1.242 0.826
Accounts Receivable - Trade, Net 2.175 0.733 2.571 1.242 0.826
Total Inventory 5.893 5.373 5.538 5.813 5.334
Prepaid Expenses 1.474 1.578 1.138 0.354 0.73
Total Assets 18.279 20.652 22.773 22.403 23.591
Property/Plant/Equipment, Total - Net 1.749 1.832 1.953 1.936 2.03
Goodwill, Net 0.781 0.781 0.781 0.781 0.781
Intangibles, Net 1.31 1.318 1.326 1.334 1.342
Other Long Term Assets, Total 1.245 1.757 1.832 2.275 2.534
Total Current Liabilities 15.477 6.348 14.735 11.911 10.491
Accounts Payable 1.866 1.28 1.502 1.12 1.328
Accrued Expenses 0.609 2.785 2.322 1.631 1.191
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 11 0.813 9.15 7.59 6.762
Other Current Liabilities, Total 2.002 1.47 1.761 1.57 1.21
Total Liabilities 16.44 16.824 16.406 14.353 13.113
Total Long Term Debt 0 9.245 0 0.653 0.572
Long Term Debt 0 9.245 0 0.653 0.572
Minority Interest -0.557 -0.431 -0.199 -0.181 -0.048
Other Liabilities, Total 1.52 1.662 1.87 1.97 2.098
Total Equity 1.839 3.828 6.367 8.05 10.478
Common Stock 0.013 0.012 0.012 0.012 0.012
Additional Paid-In Capital 258.614 268.447 268.336 268.244 266.145
Retained Earnings (Accumulated Deficit) -256.833 -264.662 -262.009 -260.235 -255.696
Other Equity, Total 0.045 0.031 0.028 0.029 0.017
Total Liabilities & Shareholders’ Equity 18.279 20.652 22.773 22.403 23.591
Total Common Shares Outstanding 12.8299 11.9118 11.9118 11.9118 11.9118
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -11.88 -16.811 -10.099 -40.94 -2.77
Cash From Operating Activities -6.62 -14.393 -3.26 -6.983 -3.317
Cash From Operating Activities 0.633 0.742 0.805 0.67 0.322
Deferred Taxes -4.73 -2.238
Non-Cash Items 6.347 9.852 3.812 35.824 0.336
Changes in Working Capital -1.72 -8.176 2.222 2.193 1.033
Cash From Investing Activities -0.093 -0.023 -0.182 -1.238 -1.296
Capital Expenditures -0.093 -0.023 -0.182 -1.238 -0.296
Cash From Financing Activities 6.832 17.422 4.199 7.111 5.502
Financing Cash Flow Items
Issuance (Retirement) of Stock, Net 6.832 12.522 0.91 6.656 2.331
Issuance (Retirement) of Debt, Net 0 4.9 3.289 0.455 3.171
Foreign Exchange Effects -0.002 0 -0.003 0.001
Net Change in Cash 0.119 3.004 0.757 -1.113 0.89
Other Investing Cash Flow Items, Total 0 -1
Cash Interest Paid 2.322 2.379 0.177
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -2.036 -11.88 -8.994 -7.203 -2.531
Cash From Operating Activities -4.159 -6.62 -6.294 -5.244 -3.952
Cash From Operating Activities 0.15 0.633 0.477 0.32 0.166
Non-Cash Items 0.629 6.347 4.856 3.618 0.51
Cash Interest Paid 2.688 2.322 2.262 2.202 2.142
Changes in Working Capital -2.902 -1.72 -2.633 -1.979 -2.097
Cash From Investing Activities -0.065 -0.093 -0.064 -0.08 -0.027
Capital Expenditures -0.065 -0.093 -0.064 -0.08 -0.027
Cash From Financing Activities 0.594 6.832 6.832 6.832 6.832
Issuance (Retirement) of Stock, Net 0.594 6.832 6.832 6.832 6.832
Issuance (Retirement) of Debt, Net 0 0 0 0
Foreign Exchange Effects 0.002 -0.001 -0.001 0
Net Change in Cash -3.628 0.119 0.473 1.507 2.853

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Cesca Therapeutics Company profile

Cesca Therapeutics
Industry: Scientific & Precision Equipment

2711 Citrus Rd
95742-6228

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

XRP/USD

0.54 Price
-1.790% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Oil - Crude

76.56 Price
-2.210% 1D Chg, %
Long position overnight fee 0.0163%
Short position overnight fee -0.0382%
Overnight fee time 22:00 (UTC)
Spread 0.030

BTC/USD

50,889.65 Price
-1.620% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

2,035.76 Price
+0.550% 1D Chg, %
Long position overnight fee -0.0185%
Short position overnight fee 0.0103%
Overnight fee time 22:00 (UTC)
Spread 0.50

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading